Abstract Details

Title Fatal Pneumocystis jirovecii (Carinii) Pneumonia Secondary to Immunosuppression for Treatment of Myasthenia Gravis: Are We Doing Enough To Protect Our Patients?

Topic Muscle Disease/Neuromuscular Junction

Presentation(s) (-)

Poster/Presentation
Number 032

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Andrew Bursaw, DO	No disclosure on file
Jeffrey C. McClean II, MD, FAAN (San Antonio Military Medical Center)	Dr. McClean has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. McClean has received personal compensation in the range of $0-$499 for serving as a Committee Member with American Academy of Neurology.
David V. Lardizabal, MD, FAAN (Charleston Area Medical Center)	Dr. Lardizabal has nothing to disclose.
Lawrence W. Ver Hoef, MD	Dr. Ver Hoef has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bowling & Christiansen. The institution of Dr. Ver Hoef has received research support from NIH. The institution of Dr. Ver Hoef has received research support from AES.